Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression

Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression

Abstract Background Osteosarcoma has been the most common primary bone malignant tumor in children and adolescents. Despite the considerable improvement in the understanding of genetic events attributing to the rapid development of molecular pathology, the current information is still lacking, partl...

Full description

Bibliographic Details
Main Authors: Ziyue Wang, Zixin Zeng, Feng Gao, Ziwei Gui, Juan Du, Ningning Shen, Yangwei Shang, Zhiqing Yang, Lifang Shang, Rong Wei, Wenxia Ma, Chen Wang
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Medical Genomics
Subjects:
Osteosarcoma
STC2 gene
Bioinformatic analysis
Risk indicator
Molecular precise medicine
Online Access:https://doi.org/10.1186/s12920-023-01456-4

Internet

https://doi.org/10.1186/s12920-023-01456-4

Similar Items